RVRC (Revium Recovery) Other Long-Term Liabilities : $0.00 Mil (As of . 20)

View and export this data going back to 2009. Start your Free Trial

What is Revium Recovery Other Long-Term Liabilities?

Revium Recovery's other long-term liabilities for the quarter that ended in . 20 was $0.00 Mil.

Revium Recovery Other Long-Term Liabilities Historical Data

The historical data trend for Revium Recovery's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Revium Recovery Other Long-Term Liabilities Chart

Revium Recovery Annual Data

Trend

Other Long-Term Liabilities

Revium Recovery Semi-Annual Data

Other Long-Term Liabilities

Revium Recovery Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Revium Recovery Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Revium Recovery's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Revium Recovery Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Revium Recovery Inc (OTCPK:RVRC) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

10 HaMenofim Street, Herzliya, ISR, 4672561

Website

https://www.reviumrecovery.com

Revium Recovery Inc is focused on the development of a disruptive, methodical, and novel proprietary Clinical Decision Support software (CDS) that will allow for measurement-based integrative care for the treatment of addiction and other mental disorders including depression and PTSD. The company's CDS combines comprehensive psychological and neurocognitive diagnostics, which allow for more informed treatment decisions; individualized treatment programs; and prediction of treatment success for each patient individually.